- Home
- AVR vs TRUE Comparison
AVR vs TRUE Comparison
Compare AVR & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- TRUE
- Stock Information
- Founded
- AVR 1999
- TRUE 2005
- Country
- AVR Australia
- TRUE United States
- Employees
- AVR N/A
- TRUE N/A
- Industry
- AVR
- TRUE Computer Software: Programming Data Processing
- Sector
- AVR
- TRUE Technology
- Exchange
- AVR NYSE
- TRUE Nasdaq
- Market Cap
- AVR 241.5M
- TRUE 213.8M
- IPO Year
- AVR 2024
- TRUE 2014
- Fundamental
- Price
- AVR $3.40
- TRUE $1.70
- Analyst Decision
- AVR Strong Buy
- TRUE Buy
- Analyst Count
- AVR 4
- TRUE 4
- Target Price
- AVR $16.50
- TRUE $4.17
- AVG Volume (30 Days)
- AVR 293.1K
- TRUE 411.6K
- Earning Date
- AVR 05-16-2025
- TRUE 04-28-2025
- Dividend Yield
- AVR N/A
- TRUE N/A
- EPS Growth
- AVR N/A
- TRUE N/A
- EPS
- AVR N/A
- TRUE N/A
- Revenue
- AVR $2,703,000.00
- TRUE $175,598,000.00
- Revenue This Year
- AVR $37.33
- TRUE $17.53
- Revenue Next Year
- AVR $141.49
- TRUE $16.56
- P/E Ratio
- AVR N/A
- TRUE N/A
- Revenue Growth
- AVR N/A
- TRUE 10.64
- 52 Week Low
- AVR $3.27
- TRUE $1.51
- 52 Week High
- AVR $8.79
- TRUE $4.62
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- TRUE 32.73
- Support Level
- AVR N/A
- TRUE $1.51
- Resistance Level
- AVR N/A
- TRUE $1.94
- Average True Range (ATR)
- AVR 0.00
- TRUE 0.11
- MACD
- AVR 0.00
- TRUE 0.03
- Stochastic Oscillator
- AVR 0.00
- TRUE 35.19
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.